-
The Pandemic’s Impact on Cancer Screening and Detection
Delays in cancer screening and diagnosis due to the COVID-19 pandemic put people at risk.
by Kevin McLaughlin
-
The Return to Work
What happens if your workplace reopens before you're ready to return or you're an essential worker? For some people who have been diagnosed with cancer, accommodations may be possible.
by Jen Tota McGivney
-
Parking Costs Take a Hidden Toll on Cancer Patients
People with cancer can pay significant costs for parking at cancer centers while receiving their treatment, a study finds.
by Marcus A. Banks
-
A Modern Family
My diagnosis with colorectal cancer at age 32 affected my fertility. As a result of my experiences, I help others who have been diagnosed with cancer understand their choices related to fertility preservation and their options for becoming a parent.
by Allison Rosen
-
Treating Cancer Patients With COVID-19: A New York City Experience
An analysis of cancer patients who were infected with the coronavirus and treated at Memorial Sloan Kettering Cancer Center in New York City suggests certain risk factors may predict more severe COVID-19.
by Anna Azvolinsky
-
What is a Super Responder?
Researchers are investigating why certain patients have an exceptional response to a particular drug.
by Bradley Jones
-
Why Are Early-Onset Cancers Rising?
Some cancers that are most commonly diagnosed in older adults are becoming increasingly prevalent in young adults.
by Kate Yandell
-
Pediatric Oncologists Underestimate Needs of Minority Parents
Research describes how communication gaps can shift extra burden to parents who are members of ethnic and racial minority groups.
by Marci A. Landsmann
-
COVID-19 Exposes Health Inequities
At a symposium held during a virtual meeting of cancer researchers, panelists discussed the disproportionate impact COVID-19 has had on Black and Latino Americans, as well as members of other minority groups.
by Kevin McLaughlin
-
Pushing Progress Forward
NCI Director Norman E. “Ned” Sharpless addresses disparities and maps out plans for the future amid “profound upheaval.”
by Kevin McLaughlin
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles